X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Under the terms of the MOU, Athersys grants global rights to Healios to develop and commercialize MultiStem (Invimestrocel) for the treatment of acute respiratory distress syndrome (ARDS).
Lead Product(s): Invimestrocel
Therapeutic Area: Pulmonary/Respiratory Diseases Product Name: MultiStem
Highest Development Status: Phase IIIProduct Type: Cell and Gene therapy
Partner/Sponsor/Collaborator: Healios K.K.
Deal Size: $151.5 million Upfront Cash: Undisclosed
Deal Type: Agreement October 10, 2023
Details:
MultiStem (invimestrocel) cell therapy is a patented regenerative medicine product that has shown the ability to promote tissue repair and healing through the production of therapeutic factors for Ischemic Stroke.
Lead Product(s): Invimestrocel
Therapeutic Area: Neurology Product Name: MultiStem
Highest Development Status: Phase IIIProduct Type: Cell and Gene therapy
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable October 10, 2023
Details:
MultiStem (invimestrocel) cell therapy is a patented regenerative medicine product that has shown the ability to promote tissue repair and healing through the production of therapeutic factors for Hemorrhagic Trauma.
Lead Product(s): Invimestrocel
Therapeutic Area: Trauma (Emergency, Injury, Surgery) Product Name: MultiStem
Highest Development Status: Phase IIProduct Type: Cell and Gene therapy
Partner/Sponsor/Collaborator: The University of Texas Health Science Center at Houston
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable June 01, 2023
Details:
MultiStem® (invimestrocel) cell therapy is a patented regenerative medicine product in clinical development that has shown the ability to promote tissue repair and healing through the production of therapeutic factors in response to signals of inammation and tissue damage.
Lead Product(s): Invimestrocel
Therapeutic Area: Neurology Product Name: MultiStem
Highest Development Status: Phase IIIProduct Type: Cell and Gene therapy
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable March 22, 2023
Details:
MultiStem (invimestrocel) cell therapy is a patented regenerative medicine product that has shown the ability to promote tissue repair and healing through the production of therapeutic factors in response to signals of inflammation and tissue damage.
Lead Product(s): Invimestrocel
Therapeutic Area: Neurology Product Name: MultiStem
Highest Development Status: Phase IIIProduct Type: Cell and Gene therapy
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable February 14, 2023
Details:
MultiStem® (invimestrocel) cell therapy is a patented regenerative medicine product in clinical development that has shown the ability to promote tissue repair and healing through the production of therapeutic factors in response to signals of inammation and tissue damage.
Lead Product(s): Invimestrocel
Therapeutic Area: Neurology Product Name: MultiStem
Highest Development Status: Phase IIIProduct Type: Cell and Gene therapy
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable January 09, 2023
Details:
MultiStem (invimestrocel) cell therapy is patented regenerative medicine product in clinical development that has shown ability to promote tissue repair and healing, such as through production of therapeutic factors in response to signals of inammation and tissue damage.
Lead Product(s): Invimestrocel
Therapeutic Area: Neurology Product Name: MultiStem
Highest Development Status: Phase IIIProduct Type: Cell and Gene therapy
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable October 04, 2022
Details:
MultiStem® cell therapy (invimestrocel) is patented regenerative medicine product has shown ability to promote tissue repair and healing in a variety of ways, such as through production of therapeutic factors in response to signals of inflammation and tissue damage.
Lead Product(s): Invimestrocel
Therapeutic Area: Neurology Product Name: MultiStem
Highest Development Status: Phase IIIProduct Type: Cell and Gene therapy
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable June 02, 2022
Details:
MultiStem® cell therapy (invimestrocel) is a patented regenerative medicine product candidate in clinical development that has shown the ability to promote tissue repair and healing in a variety of ways, such as through the production of therapeutic factors.
Lead Product(s): Invimestrocel
Therapeutic Area: Neurology Product Name: MultiStem
Highest Development Status: Phase IIIProduct Type: Cell and Gene therapy
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable May 20, 2022
Details:
Healios reported that last patient in its Phase 2/3 TREASURE study, evaluating MultiStem, a patented regenerative medicine product for the treatment of ischemic stroke, completed the 365-day follow-up visit.
Lead Product(s): Invimestrocel
Therapeutic Area: Cardiology/Vascular Diseases Product Name: MultiStem
Highest Development Status: Phase IIIProduct Type: Cell and Gene therapy
Recipient: Healios K.K
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable April 04, 2022
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 
Market Place
